| Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA S Ramakrishna, ABK Dad, J Beloor, R Gopalappa, SK Lee, H Kim Genome research 24 (6), 1020-1027, 2014 | 786 | 2014 |
| Retroviruses use CD169-mediated trans-infection of permissive lymphocytes to establish infection X Sewald, MS Ladinsky, PD Uchil, J Beloor, R Pi, C Herrmann, ... Science 350 (6260), 563-567, 2015 | 189 | 2015 |
| In vivo correction of anaemia in β-thalassemic mice by γPNA-mediated gene editing with nanoparticle delivery R Bahal, N Ali McNeer, E Quijano, Y Liu, P Sulkowski, A Turchick, YC Lu, ... Nature communications 7 (1), 13304, 2016 | 180 | 2016 |
| The effect of stocking density on stress related genes and telomeric length in broiler chickens J Beloor, HK Kang, YJ Kim, VK Subramani, IS Jang, SH Sohn, YS Moon Asian-Australasian Journal of Animal Sciences 23 (4), 437-443, 2010 | 144 | 2010 |
| Arginine-engrafted biodegradable polymer for the systemic delivery of therapeutic siRNA J Beloor, CS Choi, HY Nam, M Park, SH Kim, A Jackson, KY Lee, SW Kim, ... Biomaterials 33 (5), 1640-1650, 2012 | 74 | 2012 |
| Silencing CCR2 in macrophages alleviates adipose tissue inflammation and the associated metabolic syndrome in dietary obese mice J Kim, K Chung, C Choi, J Beloor, I Ullah, N Kim, KY Lee, SK Lee, ... Molecular Therapy-Nucleic Acids 5, 2016 | 69 | 2016 |
| Cationic cell-penetrating peptides as vehicles for siRNA delivery J Beloor, S Zeller, CS Choi, SK Lee, P Kumar Therapeutic delivery 6 (4), 491-507, 2015 | 41 | 2015 |
| Modulating HIV-1 envelope glycoprotein conformation to decrease the HIV-1 reservoir JK Rajashekar, J Richard, J Beloor, J Prévost, SP Anand, ... Cell host & microbe 29 (6), 904-916. e6, 2021 | 39 | 2021 |
| Liver-targeted cyclosporine A-encapsulated poly (lactic-co-glycolic) acid nanoparticles inhibit hepatitis C virus replication KR Jyothi, J Beloor, A Jo, MN Nguyen, TG Choi, JH Kim, S Akter, SK Lee, ... International Journal of Nanomedicine, 903-921, 2015 | 38 | 2015 |
| From in silico hit to long-acting late-stage preclinical candidate to combat HIV-1 infection SN Kudalkar, J Beloor, E Quijano, KA Spasov, WG Lee, JA Cisneros, ... Proceedings of the National Academy of Sciences 115 (4), E802-E811, 2018 | 36 | 2018 |
| Cell-specific siRNA delivery by peptides and antibodies SK Lee, A Siefert, J Beloor, TM Fahmy, P Kumar Methods in Enzymology 502, 91-122, 2012 | 34 | 2012 |
| Effective Gene Delivery into Human Stem Cells with a Cell‐Targeting Peptide‐Modified Bioreducible Polymer J Beloor, S Ramakrishna, K Nam, C Seon Choi, J Kim, SH Kim, HJ Cho, ... Small 11 (17), 2069-2079, 2015 | 33 | 2015 |
| Longitudinal bioluminescent imaging of HIV-1 infection during antiretroviral therapy and treatment interruption in humanized mice JD Ventura, J Beloor, E Allen, T Zhang, KA Haugh, PD Uchil, ... PLoS pathogens 15 (12), e1008161, 2019 | 31 | 2019 |
| Intranasal delivery of a Fas-blocking peptide attenuates Fas-mediated apoptosis in brain ischemia I Ullah, K Chung, J Oh, J Beloor, S Bae, SC Lee, M Lee, P Kumar, SK Lee Scientific reports 8 (1), 15041, 2018 | 28 | 2018 |
| Clinical evidence for a lack of cross-resistance between temsavir and ibalizumab or maraviroc R Rose, M Gartland, Z Li, N Zhou, M Cockett, J Beloor, M Lataillade, ... Aids 36 (1), 11-18, 2022 | 23 | 2022 |
| Small interfering RNA-mediated control of virus replication in the CNS is therapeutic and enables natural immunity to West Nile virus J Beloor, N Maes, I Ullah, P Uchil, A Jackson, E Fikrig, SK Lee, P Kumar Cell host & microbe 23 (4), 549-556. e3, 2018 | 20 | 2018 |
| Trileucine residues in a ligand-CPP-based siRNA delivery platform improve endosomal escape of siRNA I Ullah, K Chung, J Beloor, J Kim, M Cho, N Kim, KY Lee, P Kumar, ... Journal of Drug Targeting 25 (4), 320-329, 2017 | 20 | 2017 |
| Structural and pharmacological evaluation of a novel non-nucleoside reverse transcriptase inhibitor as a promising long acting nanoformulation for treating HIV SN Kudalkar, I Ullah, N Bertoletti, HK Mandl, JA Cisneros, J Beloor, ... Antiviral research 167, 110-116, 2019 | 19 | 2019 |
| Structural and preclinical studies of computationally designed non-nucleoside reverse transcriptase inhibitors for treating HIV infection SN Kudalkar, J Beloor, AH Chan, WG Lee, WL Jorgensen, P Kumar, ... Molecular pharmacology 91 (4), 383-391, 2017 | 18 | 2017 |
| Impact of Integrase Sequences from HIV-1 Subtypes A6/A1 on the In Vitro Potency of Cabotegravir or Rilpivirine JL Jeffrey, M St. Clair, P Wang, C Wang, Z Li, J Beloor, C Talarico, ... Antimicrobial Agents and Chemotherapy 66 (3), e01702-21, 2022 | 16 | 2022 |